BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2019
View Archived Issues
DKK2 unveiled as a potential therapeutic target for lung cancer
Read More
Where TH2 cells go, blood vessels are built
Read More
New metabolic syndrome target
Read More
Wild moms are good for offspring microbiome
Read More
First-in-human data presented for GSK-3036656
Read More
Recruitment ongoing in first in human trial of NOV-1601
Read More
JZP-458 to enter phase II/III development
Read More
Cleave Therapeutics obtains financing to advance its VCP/p97 inhibitor
Read More
BDGR-4 shows prophylactic and treatment potential for encephalitic alphaviruses
Read More
Cue Biopharma begins phase I study of CUE-101
Read More
Phase III data announced for setmelanotide in POMC and LEPR deficiency obesities
Read More
Phase I/II study of ASTX-295 recruiting participants
Read More
Serum visfatin as a diagnostic marker of patients with AMI
Read More
Apoptosis regulator Bcl-2 inhibitors patented by Zeno Royalties & Milestones
Read More
Changsha Hooz Bioscience & Technology compounds target UHRF1 and/or HDAC1
Read More
PI4KIII-beta inhibitors discovered at GlaxoSmithKline
Read More
Idorsia Pharmaceuticals describes C5aR antagonists
Read More
Favorable safety and PK data from phase Ib/IIa study of recombinant human plasma gelsolin
Read More
FDA grants approval to initiate phase Ib/II stud of L-DOS-47 plus doxorubicin in pancreatic cancer
Read More
Cancer Research UK and Hummingbird Bioscience to partner to advance HMBD-001
Read More
Servier enrolling subjects in first-in-human trial of S-65487
Read More
Chiesi Farmaceutici initiates phase I study of CHF-6523 in COPD
Read More
Novel T-cell subtype predicts risk of anaphylactic shock
Read More
Applied Therapeutics reports data from SAD portion of phase I/II study of AT-007
Read More
